Washington University in St. Louis (WU)
Application of statistical models and machine learning approaches to understand the relationship between biomarkers of Alzheimer’s disease, cognition, and disease progression. I also have worked on methods aimed at understanding AD heterogeneity as well as developing accurate diagnostic and prognostic tools for clinicians and researchers. My current interests are in understanding the relationship between AD blood-based biomarkers and cognition.